Istituto Europeo di Oncologia

Numero Anno Pubblicazione Pubblicazioni (in grassetto sono evidenziati i ricercatori dell'istituto)
1 2009
A high throughput, whole cell screen for small molecule inhibitors of the mitotic spindle checkpoint identifies OM137, a novel Aurora kinase inhibitor.
CANCER RESEARCH ;69:1509-1516.
2 2009
A positive role for Myc in TGFB-induced Snail transcription and epithelial-to-mesenchymal transition
ONCOGENE ;28:422-430.
3 2009
A role for the transcription factor HEY1 in glioblastoma
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE ;13:136-146.
4 2009
ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors.
CANCER RESEARCH ;69:8491-8498.
5 2009
Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology
BREAST ;18:4S8-S50.
6 2009
Control of NF-kappaB-dependent Transcriptional Responses by Chromatin Organization.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY ;1:a000224.
7 2009
Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA ;106:20204-20209.
8 2009
Epigenetic therapies in haematological malignancies: searching for true targets.
EUROPEAN JOURNAL OF CANCER ;45:1137-1145.
9 2009
Epigenomic profiling of cancer cells.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY ;41:127-135.
10 2009
Ethics report on interspecies somatic cell nuclear transfer research.
CELL STEM CELL ;5:27-30.
11 2009
Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells.
DISEASE MODELS & MECHANISMS ;2:56-67.
12 2009
FancyGene: dynamic visualization of gene structures and protein domain architectures on genomic loci.
BIOINFORMATICS ;25:2281-2282.
13 2009
Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation.
ZEBRAFISH ;6:417-424.
14 2009
Human CDT1 associates with CDC7 and recruits CDC45 to chromatin during S phase.
JOURNAL OF BIOLOGICAL CHEMISTRY ;284:3028-3036.
15 2009
Impact of Interaction of Polymorphic Forms of p53 Codon 72 and N-Acetylation Gene (NAT2) on the Risk of Lung Cancer in the North Indian Population.
DNA AND CELL BIOLOGY ;28:443-449.
16 2009
K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?
CANCER CHEMOTHERAPY AND PHARMACOLOGY ;65:197-199.
17 2009
Melanoma: targeting signaling pathways and RaLP.
EXPERT OPINION ON THERAPEUTIC TARGETS ;13:93-104.
18 2009
Mitochondria and vascular pathology.
PHARMACOLOGICAL REPORTS ;61:123-130.
19 2009
Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase.
BASIC RESEARCH IN CARDIOLOGY ;104:131-139.
20 2009
Protein phosphatases take the mitotic stage.
CURRENT OPINION IN CELL BIOLOGY ;21:806-815.
21 2009
Sister chromatid tension and the spindle assembly checkpoint
CURRENT OPINION IN CELL BIOLOGY ;21:785-795.
22 2009
Systems-wide analysis of a phosphatase knock down by quantitative proteomics and phosphoproteomics.
MOLECULAR & CELLULAR PROTEOMICS ;8:1908-1920.
23 2009
Tandem repeats modify the structure of human genes hosted in segmental duplications.
GENOME BIOLOGY ;10:r137.
24 2009
The C-terminal domain of CENP-C displays multiple and critical functions for mammalian centromere formation.
PLOS ONE ;4:E5832.
25 2009
The future therapeutic potential of histone demethylases: A critical analysis
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT ;12:607-615.
26 2009
The HP1alpha-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin.
EMBO REPORTS ;10:769-775.
27 2009
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.
BREAST CANCER RESEARCH AND TREATMENT ;116:295-302.
28 2009
Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab.
CLINICAL CANCER RESEARCH ;15:2010-2021.
29 2009
What to do with the Grail now that we have it? iPSCs, potentiality, and public policy.
CELL STEM CELL ;5:358-359.
30 2009
A novel t(7;13)(p12;q33 approximately q34) in AML-M2.
CANCER GENETICS AND CYTOGENETICS ;195:198-200.
31 2009
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
NATURE ;457:51-56.
32 2009
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells.
LUNG CANCER ;66:184-190.
33 2009
Epigenome microarray platform for proteome-wide dissection of chromatin-signaling networks.
PLOS ONE ;4:E6789.
34 2009
Fragment-based identification of Hsp90 inhibitors.
CHEMMEDCHEM ;4:963-966.
35 2009
Genome-Organizing Factors Top2 and Hmo1 Prevent Chromosome Fragility at Sites of S phase Transcription
CELL ;138:870-884.
36 2009
Heat-shock factor 1 controls genome-wide acetylation in heat-shocked cells.
MOLECULAR BIOLOGY OF THE CELL ;20:4976-4984.
37 2009
Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer.
CANCER LETTERS ;280:134-144.
38 2009
Identification of domains responsible for ubiquitin-dependent degradation of dMyc by glycogen synthase kinase 3beta and casein kinase 1 kinases.
MOLECULAR AND CELLULAR BIOLOGY ;29:3424-3434.
39 2009
Isolation and characterization of DUSP11, a novel p53 target gene.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE ;13:2158-2170.
40 2009
Jmjd3 contributes to the control of gene expression in LPS-activated macrophages.
EMBO JOURNAL ;28:3341-3352.
41 2009
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation.
DEVELOPMENTAL CELL ;16:466-481.
42 2009
NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint.
NATURE CELL BIOLOGY ;11:1247-1253.
43 2009
P66Shc signals to age.
AGING ;1:503-510.
44 2009
Rai acts as a negative regulator of autoimmunity by inhibiting antigen receptor signaling and lymphocyte activation.
JOURNAL OF IMMUNOLOGY ;182:301-308.
45 2009
Roles for the conserved spc105p/kre28p complex in kinetochore-microtubule binding and the spindle assembly checkpoint.
PLOS ONE ;4:E7640.
46 2009
The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts.
CELL DEATH AND DIFFERENTIATION ;16:321-330.
47 2009
The influence of catalysis on mad2 activation dynamics
PLOS BIOLOGY ;7:E10-.
48 2009
The life and miracles of kinetochores.
EMBO JOURNAL ;28:2511-2531.
49 2009
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor {kappa}B.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA ;106:14978-14983.
50 2009
Two modes of transcriptional activation at native promoters by NF-kappaB p65.
PLOS BIOLOGY ;7:E1000073-.
51 2009
When sirtuins and NF-kappaB collide.
CELL ;136:19-21.
52 2009
A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy
MATHEMATICAL AND COMPUTER MODELLING ;49:1156-1163.
53 2009
Alterations of the Notch pathway in lung cancer
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA ;106:22293-22298.
54 2009
Awaking stem cells from dormancy: growing old and fighting cancer.
EMBO MOLECULAR MEDICINE ;1:88-91.
55 2009
Be precise! The need to consider the mechanisms for CEP17 copy number changes in breast cancer
JOURNAL OF PATHOLOGY ;219:1-2.
56 2009
Fractal growth of tumors and other cellular populations: linking the mechanistic to the phenomenological modeling and vice versa
CHAOS SOLITONS & FRACTALS ;41:875-880.
57 2009
Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.
GUT ;58:1481-1489.
58 2009
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.
BLOOD ;114:5191-5200.
59 2009
Pathological definition of triple negative breast cancer.
EUROPEAN JOURNAL OF CANCER ;45 suppl 1:5-10.
60 2009
Redundant function of retinoic acid receptor isoforms in leukemogenesis unravels a prominent function of genome topology and architecture in the selection of mutagenic events in cancer.
LEUKEMIA ;23:417-419.
61 2009
The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer.
NATURE CELL BIOLOGY ;11:133-142.
62 2009
The tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development.
PLOS ONE ;4:E4273.
63 2009
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.
CELL ;138:1083-1095.
64 2009
A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA ;26:63-95.
65 2009
A reevaluation of the clinical significance of histological subtyping of non-small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY ;17:206-218.
66 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer.
ANNALS OF ONCOLOGY ;20:1178-1184.
67 2009
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor.
ONCOGENE ;28:2959-2968.
68 2009
Are surveillance procedures of clinical benefit for patients treated for ovarian cancer? A retrospective Italian multicentric study.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER ;19:367-374.
69 2009
Biomarkers for risk assessment and prevention of breast cancer.
CURRENT CANCER DRUG TARGETS  ;9:482-499.
70 2009
Breast cancer classification: time for a change
JOURNAL OF CLINICAL ONCOLOGY ;27:2427-2428.
71 2009
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
CANCER CHEMOTHERAPY AND PHARMACOLOGY ;63:275-280.
72 2009
Chronic pancreatitis: Report from a multicenter Italian survey (PanCroInfAISP) on 893 patients.
DIGESTIVE AND LIVER DISEASE ;41:311-317.
73 2009
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study).
EUROPEAN JOURNAL OF CANCER ;45:3189-3197.
74 2009
Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer.
JOURNAL OF CLINICAL ONCOLOGY ;27:5693-5699.
75 2009
Communication skills and raising awareness in clinical practice: an Italian experience
ECANCERMEDICALSCIENCE ;3:135.
76 2009
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung.
MODERN PATHOLOGY ;22:709-717.
77 2009
Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series.
VACCINE ;27:A30-A33.
78 2009
Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years.
ONCOLOGIST ;14:201-212.
79 2009
Epidemiology of pancreatic cancer: an overview.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY ;6:699-708.
80 2009
Eps8 regulates axonal filopodia in hippocampal neurons in response to brain-derived neurotrophic factor (BDNF).
PLOS BIOLOGY ;7:E1000138.
81 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
BRITISH JOURNAL OF CANCER ;101:2048-2054.
82 2009
For the sake of clarity about pT4 category of colorectal cancer.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE ;133:340-.
83 2009
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis.
JOURNAL OF HEPATOLOGY ;50:1142-1154.
84 2009
Human Papilloma Virus (HPV) in head and neck region: review of literature.
ACTA OTORHINOLARYNGOLOGICA ITALICA ;29:119-126.
85 2009
Hyperamylasaemia and/or hyperlipasaemia: Incidence and underlying causes in hospitalized patients with non-pancreatic diseases.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY ;44:237-241.
86 2009
Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors.
HUMAN PATHOLOGY ;40:30-40.
87 2009
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
BREAST CANCER RESEARCH AND TREATMENT ;116:359-369.
88 2009
Information-related changes in contact patterns may trigger oscillations in the endemic prevalence of infectious diseases.
JOURNAL OF THEORETICAL BIOLOGY ;256:473-478.
89 2009
Intakes of Red Meat, Processed Meat, and Meat Mutagens Increase Lung Cancer Risk.
CANCER RESEARCH ;69:932-939.
90 2009
Integrating molecular profiling, histological type and other variables: defining the fingerprint of responsiveness to treatment
BREAST ;18:s32-s36.
91 2009
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype:prognostic implications of EGFR immunoreactivity.
BREAST CANCER RESEARCH AND TREATMENT ;116:317-328.
92 2009
Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
BREAST CANCER RESEARCH AND TREATMENT ;117:211-214.
93 2009
Natural History of Acute Pancreatitis: A Long-Term Population-Based Study.
AMERICAN JOURNAL OF GASTROENTEROLOGY ;104:2797-2805.
94 2009
Pancreas: A new model to predict mortality in acute pancreatitis.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY ;6:203-204.
95 2009
Plasmablastic lymphoma: a review
ORAL DISEASES ;15:38-45.
96 2009
Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study.
AMERICAN JOURNAL OF GASTROENTEROLOGY ;104:1147-1158.
97 2009
Re: ABO Blood Group and the Risk of Pancreatic Cancer.
JOURNAL OF THE NATIONAL CANCER INSTITUTE ;101:1156-1157.
98 2009
Re: Skin signs in acute pancreatitis: frequency and implications for prognosis.
JOURNAL OF INTERNAL MEDICINE ;266:220-.
99 2009
Re:Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer
JOURNAL OF CLINICAL ONCOLOGY ;27:e141-e142.
100 2009
Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research.
BREAST JOURNAL ;15:291-295.
101 2009
Review and meta-analysis on Vitamin D Receptor polymorphisms and cancer risk.
CARCINOGENESIS ;30:1170-1180.
102 2009
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy.
BMC CANCER ;9:352.
103 2009
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls.
BMC CANCER ;9:7.
104 2009
Role of traditional and new biomarkers in breast carcinogenesis
ECANCERMEDICALSCIENCE ;3:157.
105 2009
Skin signs in acute pancreatitis: frequency and implications for prognosis.
JOURNAL OF INTERNAL MEDICINE ;265:299-301.
106 2009
SNPs in ultraconserved elements and familial breast cancer risk
CARCINOGENESIS ;30:544-545.
107 2009
Sostenibilità della disciplina dei dati genetici e dei campioni biologici
IGIENE E SANITA PUBBLICA ;65:291-303.
108 2009
Temporal Trends in Incidence and Severity of Acute Pancreatitis in Lüneburg County, Germany: A Population-Based Study.
PANCREATOLOGY ;9:420-426.
109 2009
The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells.
JOURNAL OF EXPERIMENTAL MEDICINE ;206:623-635.
110 2009
The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS ;1787:774-780.
111 2009
The changing character of acute pancreatitis: epidemiology, etiology, and prognosis.
CURRENT GASTROENTEROLOGY REPORTS ;11:97-103.
112 2009
The dynamics of tumour-vasculature interaction suggest low-dose, time-dense anti-angiogenic schedulings
CELL PROLIFERATION ;42:317-329.
113 2009
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.
BMC GENOMICS ;2:40.
114 2009
The Harmless Acute Pancreatitis Score: A Clinical Algorithm for Rapid Initial Stratification of Non-Severe Disease
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY ;7:702-705.
115 2009
Tumor deposits are encountered in advanced colorectal cancer and other adenocarcinomas: an expanded classification with implications for colorectal cancer staging system including a unifying concept of in-transit metastases.
MODERN PATHOLOGY ;22:410-415.
116 2009
Which factors affect pulmonary function after lung metastasectomy?
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY ;35:792-796.
117 2009
Before they were gut dendritic cells.
IMMUNITY ;31:454-456.
118 2009
Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial.
ANNALS OF ONCOLOGY ;20:935-940.
119 2009
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
ANNALS OF ONCOLOGY ;20:1489-1498.
120 2009
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.
BREAST ;18:84-88.
121 2009
Cardiotossicità da agenti antitumorali
PRATICA MEDICA & ASPETTI LEGALI ;3:155-161.
122 2009
"Care and self-care" "God as a mirror of the self".
JOURNAL OF CANCER EDUCATION ;24:80-82.
123 2009
Clinical and pharmacological phase I evaluation of exherin (ADH-1), a selective anti n-cadherin peptide in patients with n-cadherin expressing solid tumours.
ANNALS OF ONCOLOGY ;20:741-745.
124 2009
Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.
PLOS ONE ;4:E7056.
125 2009
Dendritic cells in intestinal homeostasis and disease.
JOURNAL OF CLINICAL INVESTIGATION ;119:2441-2450.
126 2009
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.
CLINICAL TRIALS ;6:272-287.
127 2009
Erlotinib combined with cyclosporine in a liver-transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer.
JOURNAL OF THORACIC ONCOLOGY ;4:138-139.
128 2009
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.
JOURNAL OF CLINICAL ONCOLOGY ;27:663-671.
129 2009
Gastric cancer
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY ;71:127-164.
130 2009
Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration.
ANNALS OF ONCOLOGY ;20:1747-1748.
131 2009
HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future.
EXPERT REVIEW OF VACCINES ;8:1513-1526.
132 2009
Immunizing against breast cancer: A new swing for an old sword
BREAST ;18:S51-S54.
133 2009
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
ANTI-CANCER DRUGS ;20:197-203.
134 2009
Interleukin-23: Linking Mesenteric Lymph Node Dendritic Cells With Th1 Immunity in Crohn's Disease.
GASTROENTEROLOGY ;137:1566-1570.
135 2009
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
JOURNAL OF THE NATIONAL CANCER INSTITUTE ;101:1174-1181.
136 2009
Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.
MUCOSAL IMMUNOLOGY ;2:340-350.
137 2009
Investigations after adjuvant therapy.
CANCER TREAT RES ;151:331-352.
138 2009
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
BREAST CANCER RESEARCH AND TREATMENT ;116:491-500.
139 2009
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
BREAST CANCER RESEARCH AND TREATMENT ;113:137-144.
140 2009
Is there a role for 'modified VAD' in the treatment of multiple myeloma?
ECANCERMEDICALSCIENCE ;3:136.
141 2009
Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting
BREAST ;18:S137-S140.
142 2009
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
NEW ENGLAND JOURNAL OF MEDICINE ;361:766-776.
143 2009
Long QT syndrome and torsade de pointes after anthracycline chemotherapy
ECANCERMEDICALSCIENCE ;3:147.
144 2009
LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages.
FASEB JOURNAL ;23:2898-2908.
145 2009
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
BREAST CANCER RESEARCH AND TREATMENT ;118:385-394.
146 2009
Molecular target therapy for gastroenteropancreatic endocrine tumours: Biological rationale and clinical perspectives.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY ;72:110-124.
147 2009
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
LANCET ONCOLOGY ;10:943-949.
148 2009
On Optimal Delivery of Combination Therapy for Tumors.
MATHEMATICAL BIOSCIENCES ;222:13-26.
149 2009
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
BREAST CANCER RESEARCH AND TREATMENT ;117:319-324.
150 2009
Pediatric medulloblastoma: Toxicity of current treatment and potential role of protontherapy.
CANCER TREATMENT REVIEWS ;35:79-96.
151 2009
Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours.
EUROPEAN JOURNAL OF CANCER ;45:2116-2122.
152 2009
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer.
EUROPEAN JOURNAL OF CANCER ;45:1153-1161.
153 2009
Preoperative chemo- and endocrine therapy.
CANCER TREAT RES ;151:103-120.
154 2009
QTc prolongation assessment in anticancer drug development: Clinical and methodological issues
ECANCERMEDICALSCIENCE ;3:130-.
155 2009
Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy.
JOURNAL OF THE NATIONAL CANCER INSTITUTE ;101:1735-1736.
156 2009
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.
EUROPEAN JOURNAL OF CANCER ;45:561-571.
157 2009
Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
VACCINE ;27:a34-a38.
158 2009
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.
CANCER CHEMOTHERAPY AND PHARMACOLOGY ;64:301-306.
159 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
ANNALS OF ONCOLOGY ;20:1344-1351.
160 2009
The gut immune barrier and the blood-brain barrier: are they so different?
IMMUNITY ;31:722-735.
161 2009
Tossicità cardiaca da chemioterapici. Gestione clinica
IL CARDIOLOGO ;9:18-24.
162 2009
Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes.
JOURNAL OF MEDICAL VIROLOGY ;81:271-277.
163 2009
Utility of adjuvant systemic therapy in melanoma.
ANNALS OF ONCOLOGY ;20:VI30-VI34.
164 2009
A parathyroid carcinoma within a cold thyroid nodule
ECANCERMEDICALSCIENCE ;3:150.
165 2009
Carcinoma, tuberculosis and elastofibroma in one patient: is (18F) FDG-PET/CT helpful?
REVISTA ESPAÑOLA DE MEDICINA NUCLEAR ;28:22-25.
166 2009
Confocal laser endomicroscopy diagnosis of gastric adenocarcinoma in a patient treated for gastric diffuse large-B-cell lymphoma.
DIGESTIVE AND LIVER DISEASE ;41:447-449.
167 2009
Confocal laser endomicroscopy for the detection of mucosal changes in ileal pouch after restorative proctocolectomy.
DIGESTIVE AND LIVER DISEASE ;41:578-585.
168 2009
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ;36:1713-1742.
169 2009
Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients.
BLOOD ;113:2265-2274.
170 2009
Hematologic toxicity and double autografting of Stem Cells after myeloablative activities of yttrium-90 ibritumomab tiuxetan
JOURNAL OF CLINICAL ONCOLOGY ;27:1145-1146.
171 2009
In vivo repeatability of automated volume calculations of small pulmonary nodules with CT.
AMERICAN JOURNAL OF ROENTGENOLOGY ;192:1657-1661.
172 2009
Intra- and Interobserver Agreement and Impact of Arterial Input Selection in Perfusion CT Measurements Performed in Squamous Cell Carcinoma of the Upper Aerodigestive Tract.
AMERICAN JOURNAL OF NEURORADIOLOGY ;30:1107-1115.
173 2009
Joint Practice Guidelines for Radionuclide Lymphoscintigraphy for Sentinel Node Localization in Oral/Oropharyngeal Squamous Cell Carcinoma.
ANNALS OF SURGICAL ONCOLOGY ;16:3190-3210.
174 2009
Joint Practice Guidelines for Radionuclide Lymphoscintigraphy for Sentinel Node Localization in Oral/Oropharyngeal Squamous Cell Carcinoma.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ;36:1915-1936.
175 2009
Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer.
RADIOTHERAPY AND ONCOLOGY ;93:14-17.
176 2009
Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS ;24:659-665.
177 2009
Magnetic resonance imaging of primary breast lymphoma.
RADIOLOGIA MEDICA ;114:915-924.
178 2009
MRI features of cotyledonoid dissecting leiomyoma of the uterus.
TUMORI ;95:532-534.
179 2009
Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
CLINICAL & TRANSLATIONAL ONCOLOGY ;11:48-53.
180 2009
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ;36:1407-1416.
181 2009
Peptide receptor therapies in neuroendocrine tumors.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION ;32:360-369.
182 2009
Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY ;33:552-559.
183 2009
Quality assurance of 3D-CRT: indications and difficulties in their applications.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY ;70:24-38.
184 2009
Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS ;24:145-154.
185 2009
Radiation survey around a Liac mobile electron linear accelerator for intraoperative radiation therapy.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS ;10:131-138.
186 2009
Rapid determination of (90)Sr impurities in freshly "generator eluted"(90)Y for radiopharmaceutical preparation.
APPLIED RADIATION AND ISOTOPES ;67:1874-1877.
187 2009
Salvage high dose rate brachytherapy after primary external beam irradiation in localized prostate cancer: a case report.
TUMORI ;95:553-556.
188 2009
The role of dosimetry in the high activity 90Y-ibritumomab tiuxetan regimens: two cases of abnormal biodistribution.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS ;24:271-275.
189 2009
Ultrasound-guided vacuum assisted breast biopsy in the assessment of C3 breast lesions by ultrasound-guided fine needle aspiration cytology: results and costs in comparison with surgery.
BREAST ;18:73-77.
190 2009
A massive gastric xanthomatosis.
ENDOSCOPY ;41:E54-E55.
191 2009
Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group
JOURNAL OF CLINICAL ONCOLOGY ;27:2916-2923.
192 2009
Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy
RADIOTHERAPY AND ONCOLOGY ;90:213-220.
193 2009
Awareness is the key to conquering male breast cancer
SOUTHERN MEDICAL JOURNAL ;102:677.
194 2009
Axillary metastases in breast cancer patients with negative sentinel nodes: A follow-up of 3548 cases.
EUROPEAN JOURNAL OF CANCER ;45:1381-1388.
195 2009
Bowel preparation before colonoscopy in the era of mass screening for colo-rectal cancer: A practical approach
DIGESTIVE AND LIVER DISEASE ;41:87-95.
196 2009
Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy
BREAST ;18:s90-s92.
197 2009
Building a robotic program
SCANDINAVIAN JOURNAL OF SURGERY ;98:72-75.
198 2009
Case mix at the European Institute of Oncology: first report of the Tumour Registry, years 2000-2002
ECANCERMEDICALSCIENCE ;3:149.
199 2009
Circular clamp excision: a new technique for lung metastasectomy.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY ;138:244-245.
200 2009
Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
ANNALS OF SURGICAL ONCOLOGY ;16:2018-2027.
201 2009
Comparison between endoscopic and surgical treatment of screen-detected vs. non-screen-detected colorectal cancers
ECANCERMEDICALSCIENCE ;3:142.
202 2009
Compartmental surgery in tongue tumours: description of a new surgical technique.
ACTA OTORHINOLARYNGOLOGICA ITALICA ;29:259-264.
203 2009
Conservative surgery in patients with multifocal/multicentric breast cancer
BREAST CANCER RESEARCH AND TREATMENT ;113:577-583.
204 2009
Correlation between administered treatment and patient's Living Will
ECANCERMEDICALSCIENCE ;3:158.
205 2009
Cutaneous melanoma in the elderly.
MELANOMA RESEARCH ;19:125-134.
206 2009
Desmoid tumors of the Anterior Abdominal Wall: results from a monocentric surgical experience and review of the literature
ANNALS OF SURGICAL ONCOLOGY ;16:1642-1649.
207 2009
Does a personalized approach improve patient satisfaction in thoracic oncology?
AMERICAN JOURNAL OF MANAGED CARE ;15:361-367.
208 2009
Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality?
BREAST CANCER RESEARCH AND TREATMENT ;118:623-633.
209 2009
Early oral versus "traditional" postoperative feeding in gynecologic oncology patients undergoing intestinal resection: a randomized controlled trial.
ANNALS OF SURGICAL ONCOLOGY ;16:1660-1668.
210 2009
Early stage gastric diffuse large B-cell lymphomas: results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy.
LEUKEMIA & LYMPHOMA ;50:925-931.
211 2009
Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer. A comparison between dose-volume constraints and NTCP use
STRAHLENTHERAPIE UND ONKOLOGIE ;185:384-389.
212 2009
FIGO COMMITTEE ON GYNECOLOGIC ONCOLOGY. FIGO staging for uterine sarcomas
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS ;104:179.
213 2009
FIGO COMMITTEE ON GYNECOLOGIC ONCOLOGY. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS ;105:103-104.
214 2009
Full robotic left colon and rectal cancer resection: technique and early outcome.
ANNALS OF SURGICAL ONCOLOGY ;16:1274-1278.
215 2009
How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY ;200:235.e1-235.e6.
216 2009
In Crescentic IgA Nephropathy, Fractional Excretion of IgG in Combination with Nephron Loss Is the Best Predictor of Progression and Responsiveness to Immunosuppression.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY ;4:929-935.
217 2009
Integrated breast conservation and intraoperative radiation therapy
BREAST ;18:s98-s102.
218 2009
Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis
BJU INTERNATIONAL ;104:1624-1630.
219 2009
Intraprostatic fiducial markers: a potential application for ultrasound-guided radiotherapy in prostate cancer
ECANCERMEDICALSCIENCE ;3:143.
220 2009
Invited commentary
ANNALS OF THORACIC SURGERY ;88:397-398.
221 2009
Is electron beam intraoperative radiotherapy (ELIOT) safe in pregnant women with early breast cancer? In vivo dosimetry to assess fetal dose.
ANNALS OF SURGICAL ONCOLOGY ;16:100-105.
222 2009
Laparoscopic rectal resection for cancer: effects of conversion on short-term outcome and survival.
ANNALS OF SURGICAL ONCOLOGY ;16:1279-1286.
223 2009
Laser surgery for early glottic cancer
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY ;135:385-390.
224 2009
Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases
HEPATO-GASTROENTEROLOGY ;56:829-834.
225 2009
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO).
BREAST CANCER RESEARCH AND TREATMENT ;117:333-338.
226 2009
Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases.
BREAST CANCER RESEARCH AND TREATMENT ;114:97-101.
227 2009
Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan.
GYNECOLOGIC ONCOLOGY ;114:64-68.
228 2009
Perioperative Intravenous Glutamine Supplemetation in Major Abdominal Surgery for Cancer: A Randomized Multicenter Trial.
ANNALS OF SURGERY ;250:684-690.
229 2009
Periurethral suspension stitch during robot assisted laparoscopic radical prostatectomy: description of the technique and continence outcomes
EUROPEAN UROLOGY ;56:472-478.
230 2009
Preserving life and conserving the breast.
LANCET ONCOLOGY ;10:736.
231 2009
Prone breast radiotherapy in a patient with early stage breast cancer and a large pendulous breast
TUMORI ;95:394-397.
232 2009
Re: Assessment of early continence after reconstruction of the periprostatic tissues in patients undergoing computer assisted (robotic) prostatectomy: results of a 2 group parallel randomized controlled trial: M. Menon, F. Muhletaler, M. Campos and J
JOURNAL OF UROLOGY ;181:1500-1501.
233 2009
Re: The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence.
AMERICAN JOURNAL OF SURGERY ;198:461-462.
234 2009
Reactive oxygen species and antioxidants: implications for clinical nutrition
NUTRITIONAL THERAPY & METABOLISM ;27:62-72.
235 2009
Reduction of Postoperative Complication Rate with the Use of Early Oral Feeding in Gynecologic Oncologic Patients Undergoing a Major Surgery: A Randomized Controlled Trial.
ANNALS OF SURGICAL ONCOLOGY ;16:3101-3110.
236 2009
Revised FIGO staging for carcinoma of the cervix.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS ;105:107-108.
237 2009
Right pelvic mass in a patient with a radically resected carcinoid of the appendix
GUT ;58:1200-1259.
238 2009
Robotic approach for cervical cancer: comparison with laparotomy. A case control study.
GYNECOLOGIC ONCOLOGY ;115:60-64.
239 2009
Robotic surgery: changing the surgical approach for endometrial cancer in a referral cancer center.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY ;16:427-431.
240 2009
Robotic vs open prostatectomy in a laparoscopically naive centre: a matched-pair analysis.
BJU INTERNATIONAL ;104:991-995.
241 2009
Robotic-assisted radical prostatectomy: a review of current outcomes.
BJU INTERNATIONAL ;104:1428-1435.
242 2009
Role of prophylactic central neck dissection in cN0 papillary thyroid cancer.
ACTA OTORHINOLARYNGOLOGICA ITALICA ;29:61-69.
243 2009
Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: Operative technique and clinical outcome
GYNECOLOGIC ONCOLOGY ;114:173-177.
244 2009
Segmentectomy for carcinoid arising from an accessory cardiac bronchus.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY ;35:537.
245 2009
Sentinel node biopsy in patients with previous breast aesthetic surgery.
ANNALS OF SURGICAL ONCOLOGY ;16:989-992.
246 2009
Sentinel node in colon cancer
NOWOTWORY JOURNAL OF ONCOLOGY ;59:120e-122e.
247 2009
Severe skin necrosis after breast reconstruction with a transverse rectus abdominis musculocutaneous flap in methylenetetrahydrofolate reductase deficiency
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY ;62:e356-e359.
248 2009
Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ;74:115-125.
249 2009
Surgery and radiotherapy in the treatment of cutaneous melanoma.
ANNALS OF ONCOLOGY ;20:VI 22-VI 29.
250 2009
Surgery Illustrated - Focus on Details Anatomical reconstruction of the rhabdosphincter after radical prostatectomy
BJU INTERNATIONAL ;104:274-281.
251 2009
Surveillance procedures for patients for cervical carcinoma: a review of the literature.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER ;19:306-313.
252 2009
Synchronous pleuro - renal solitary fiborous tumors: a new clinical-pathological finding
MINERVA CHIRURGICA ;64:669-671.
253 2009
Systemic therapies for non-metastatic prostate cancer: review of the literature.
ONKOLOGIE ;32:359-363.
254 2009
The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY ;72:65-75.
255 2009
The National Center for Oncological Hadron Therapy: status of the project and future clinical use of the facility.
TUMORI ;95:169-176.
256 2009
The surgical margin status after breast-conserving surgery: discussion of an open issue.
BREAST CANCER RESEARCH AND TREATMENT ;113:397-402.
257 2009
Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome.
ANNALS OF ONCOLOGY ;20:1008-1012.
258 2009
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis.
LUNG CANCER ;64:371-377.
259 2009
Vascular catheter mimicking persistent left superior vena cava.
THORACIC AND CARDIOVASCULAR SURGEON ;57:185-186.
260 2009
A phase I- II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma
BRITISH JOURNAL OF CANCER ;100:28-36.
261 2009
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
ANNALS OF ONCOLOGY ;20:660-665.
262 2009
Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis
BREAST CANCER RESEARCH AND TREATMENT ;114:599-605.
263 2009
Benign splenosis mimicking peritoneal seeding in a bladder cancer patient: a case report
CASES JOURNAL ;2:9294.
264 2009
Breast cancer and pregnancy: how safe is trastuzumab?
NAT REV CLIN ONCOL ;6:367-370.
265 2009
Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer?
ANNALS OF SURGICAL ONCOLOGY ;16:3380-3387.
266 2009
Breast-feeding after breast cancer: if you wish, madam.
BREAST CANCER RESEARCH AND TREATMENT ;114:7-12.
267 2009
Breastfeeding after breast cancer: shifting the paradigm.
ECANCERMEDICALSCIENCE ;:-.
268 2009
Capecitabine Initially Concomitant to Radiotherapy Then Perioperatively Administered in Locally Advanced Rectal Cancer.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ;75:421-427.
269 2009
Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancy
JOURNAL OF THORACIC ONCOLOGY ;4:559-560.
270 2009
Cholangiocarcinoma
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY ;69:259-270.
271 2009
Circulating endothelial cells as biomarkers for angiogenesis in tumor progression
FRONTIERS IN BIOSCIENCE ;S1:304-318.
272 2009
Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype.
BRITISH JOURNAL OF HAEMATOLOGY ;144:803-805.
273 2009
Cisplatin, Etoposide and Continuous Infusion Bleomycin in Patients with Testicular Germ Cell Tumors: Efficacy and Toxicity Data from a Retrospective Study.
JOURNAL OF CHEMOTHERAPY ;21:687-692.
274 2009
Clinical genetic testing for familial melanoma in Italy: A cooperative study.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY ;61:775-782.
275 2009
Coagulation Disorders in Patients with Cancer: Nontunneled Central Venous Catheter Placement with US Guidance--A Single-Institution Retrospective Analysis.
RADIOLOGY ;253:249-252.
276 2009
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
HUMAN MOLECULAR GENETICS ;18:4442-4456.
277 2009
Contribution of Granulocyte Colony-Stimulating Factor to the Acute Mobilization of Endothelial Precursor Cells by Vascular Disrupting Agents.
CANCER RESEARCH ;69:7524-7528.
278 2009
Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial.
EUROPEAN JOURNAL OF CANCER ;45:1201-1208.
279 2009
Detection of a cardiac mass by [18F]FDG-PET/CT: a rare case.
ECANCERMEDICALSCIENCE ;3:152.
280 2009
Dietary Changes After Breast Cancer in Women Without Hot Flashes: A Simple and Inexpensive Way to Target Tumor and Host?
JOURNAL OF CLINICAL ONCOLOGY ;27:323-325.
281 2009
Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial.
JOURNAL OF CLINICAL ONCOLOGY ;27:2962-2969.
282 2009
Effects of Transdermal Buprenorphine on Patients-reported Outcomes in Cancer Patients Results From the Cancer Pain Outcome Research (CPOR) Study Group
CLINICAL JOURNAL OF PAIN ;25:671-682.
283 2009
ESPEN Guidelines on Parenteral Nutrition: Central Venous Catheters (access, care, diagnosis and therapy of complications).
CLINICAL NUTRITION ;28:365-377.
284 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup
JOURNAL OF CLINICAL ONCOLOGY ;27:1419-1425.
285 2009
Evidences for association of the CASP8-652 6n del promoter polymorphism with age at diagnosis in familial breast cancer cases
BREAST CANCER RESEARCH AND TREATMENT ;113:607-608.
286 2009
Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS ;670:6-14.
287 2009
GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
FERTILITY AND STERILITY ;92:e33.
288 2009
Health-related quality of life in patients with hormone refractory prostate cancer receiving gefitinib.
UROLOGIA INTERNATIONALIS ;82:196-202.
289 2009
Interference of antibiotic therapy on blood cultures time-to-positivity: analysis of a 5-year experience in an oncological hospital.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES ;28:95-98.
290 2009
Is it time to test metformin in breast cancer clinical trials?
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION ;18:701-705.
291 2009
Laboratory-based management of microbiological alerts: Effects of an automated system on the surveillance and treatment of nosocomial infections in an oncology hospital
ECANCERMEDICALSCIENCE ;3:137.
292 2009
Management of Anaplastic Large-Cell Lymphoma During Pregnancy.
JOURNAL OF CLINICAL ONCOLOGY ;27:e75-e77.
293 2009
Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia.
ONCOLOGY REPORTS ;21:193-198.
294 2009
Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC.
CANCER CAUSES & CONTROL ;20:1757-1762.
295 2009
Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant.
EUROPEAN JOURNAL OF CANCER ;45:3054-3063.
296 2009
Non-epithelial ovarian cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
ANNALS OF ONCOLOGY ;20:iv24-iv26.
297 2009
Normal-release Oral Morphine Starting Dose in Cancer Patients With Pain
CLINICAL JOURNAL OF PAIN ;25:386-390.
298 2009
Pattern and quality of care of cancer pain management. Results from the cancer pain outcome research study group
BRITISH JOURNAL OF CANCER ;100:1566-1574.
299 2009
Perioperative Serum VEGF and Extracellular Domains of EGFR and HER2 in Early Breast Cancer.
ANTICANCER RESEARCH ;29:5111-5119.
300 2009
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer.
CANCER CHEMOTHERAPY AND PHARMACOLOGY ;64:673-680.
301 2009
Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer.
ANNALS OF ONCOLOGY ;20:498-502.
302 2009
Plasma retinol and prognosis of postmenopausal breast cancer patients.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION ;18:42-48.
303 2009
Platinum, Anthracycline, and Alkylating Agent-Based Chemotherapy for Ovarian Carcinosarcoma.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER ;19:1142-1146.
304 2009
Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab.
CLINICAL CANCER RESEARCH ;15:7652-7657.
305 2009
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.
ANNALS OF ONCOLOGY ;20:1993-1999.
306 2009
Proceedings of the International Consensus Conference on Breast Cancer Risk, genetics, & Risk Management, April, 2007
BREAST JOURNAL ;15:4-16.
307 2009
Psychotropic drugs associated with corrected QT interval prolongation.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY ;29:9-15.
308 2009
Quantification of circulating endothelial cells by flow cytometry.
CLINICAL CANCER RESEARCH ;15:3640.
309 2009
Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia.
CLINICAL CANCER RESEARCH ;15:7053-7060.
310 2009
Randomized Double-Blind 2 x 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women.
JOURNAL OF CLINICAL ONCOLOGY ;27:3749-3756.
311 2009
Rectal cancer
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY ;70:160-182.
312 2009
Retinoids and breast cancer prevention
RECENT RESULTS IN CANCER RESEARCH ;181:77-82.
313 2009
Rituximab in lymphocyte-predominant Hodgkin disease.
ONCOLOGY ;76:26-29.
314 2009
Role of nucleophosmin in acute myeloid leukemia
EXPERT REVIEW OF ANTICANCER THERAPY ;9:1283-1294.
315 2009
Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents
ONCOLOGY ;77:358-365.
316 2009
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients.
SUPPORTIVE CARE IN CANCER ;17:279-284.
317 2009
Systemic therapy as a first choice treatment for idiopathic granulomatous mastitis.
JOURNAL OF CUTANEOUS PATHOLOGY ;36:689-691.
318 2009
The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER ;1796:27-32.
319 2009
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
ANNALS OF ONCOLOGY ;20:1319-1329.
320 2009
Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.
CLINICAL CANCER RESEARCH ;15:267-273.
321 2009
Vitamin D and skin cancer: a meta-analysis.
EUROPEAN JOURNAL OF CANCER ;45:634-641.
322 2009
Weekly epirubicin in the treatment of gestational breast cancer (GBC)
BREAST CANCER RESEARCH AND TREATMENT ;115:591-594.
323 2009
Why vitamin D for cancer patients?
ECANCERMEDICALSCIENCE ;3:160.